a comprehensive manufacturing execution system for the precision therapeutics workflow

challenging the MES status quo

The manufacturing of pharmaceutical products is fraught with complexity and time constraints, frequently leading to delays, deviations, and escalating costs. Traditional methods rely on cumbersome, paper-based ecosystems and inflexible electronic systems, further compounded by non-compliant spreadsheets that create bottlenecks and delay product releases. 

introducing L7 MES

L7 MES is a flexible, digital, and process-oriented solution designed to overcome traditional pharmaceutical manufacturing bottlenecks, while ensuring 21 CFR Part 11 compliance for the production of small molecules, biologics, and cell and gene therapy products.

Efficient Recipe Management

Rapid configuration of Master Batch Records, Intermediates, and Drug Product recipes.

Enhanced Operational Control

Supports configurable electronic signatures, sample plan management, and label reconciliation.

Comprehensive Documentation Integration

Enables Electronic Batch Records (EBR), Bill of Materials (BOM), Sample Plan Management, Specifications, Quality Review, Signature Sign-Off, and automatic Batch Reports.

L7 MES outperforms traditional manufacturing execution systems

L7 MES is part of the L7|ESP unified platform

L7 MES is integrated into the L7|ESP unified platform, sharing a common database with LIMS and inventory systems. It leverages the existing L7|ESP workflow configurations to accurately represent and manage the manufacturing process. Throughout production, it collects samples to be analyzed by LIMS. Additionally, L7|ESP supports enhancements with data trending and charting tools, enabling both single-batch and cross-batch analysis and reporting.

L7 MES app




what customers are saying

The decision to deploy L7|ESP reflects our commitment to staying at the forefront of innovation in this dynamic field.
Mike O'Mara

Chief Operating Officer, Cellipont Biosciences

ready to take your MES data to the next level?